The Corning® CellBIND® surface, the first novel cell culture surface treatment in over 20 years, is designed to improve cell attachment under difficult conditions, such as reduced-serum or serum-free medium, resulting in higher cell yields. It is also useful for growing "difficult" cells such as primary cultures or transfected cells over expressing proteins. Developed by Corning scientists, this patented technology (U.S. Patent 6,617,152) uses a novel microwave plasma process for treating the culture surface. This process improves cell attachment by incorporating significantly more oxygen into the cell culture surface than traditional plasma or corona discharge treatments, rendering it more hydrophilic (wettable) and increasing the stability of the surface. Unlike biological co...Read more
Receive your quote directly from Corning Life Sciences.
SelectScience Members can achieve membership status by writing product reviews. This helps other members to better understand the Reviewer's experience and expertise.
Status: No. Reviews Published: Member 0 1-4 5-14 15+ By Invitation
Reviewers are also encouraged to publish a 'public profile' so others can benefit from a further understanding of the Reviewer's applications and expertise.
Write a review today>>
Reviewer(what's this)Membership Status
Member since: 2007
Organization: University of North Texas Health Science Center
Unlike biological coatings, the Corning® CellBIND® surface is a nonbiological surface that requires no special handling or storage. Because the polymer is treated, rather than coated, the surface is more consistent and stable. This enhanced cell performance has already led to a major biotechnology company choosing Corning® roller bottles with the Corning® CellBIND® surface for producing a new FDA approved protein therapeutic.